1.苏青, 臧丽. 胰岛素抵抗的历史、机制和管理 [J] . 中华糖尿病杂志, 2023, 15(1) : 6-13. DOI: 10.3760/cma.j.cn115791-20220905-00447.2.朱大龙,母义明. 胰岛素抵抗相关临床问题专家共识(2022版).中华糖尿病杂志 2022 年12 月第 14 卷第 12 期 Chin J Diabetes Mellitus, December 2022, Vol. 14, No. 123.Lean ME,Leslie WS,Barnes AC,et al. Primary care-led weight management for remission of type 2 diabetes(DiRECT):an open ?label,cluster-randomised trial. The Lancet,2018,17:541?551.4.邹大进,纪立农. 缓解2型糖尿病中国专家共识.中国糖尿病杂志2021年9月第29卷第9期.5.洪天配,田勍,杨进. 肠促胰素效应的发现及其临床应用展望[J] .中华内分泌代谢杂志,2018,34 (8): 629-633. DOI: 10.3760/cma.j.issn.1000-6699.2018.08.0016.宋林阳,胡依萌,徐焱成,郭立新.胰岛素抵抗的再认识[J].中华糖尿病杂志,2022,14(12):1341-1347.DOI:10.3760/cma.j.cn115791-20220921-00485.7.Svedberg J?Biorntorp P?Smith U?et al.Free-fatty acid inhibiton of insulin binding?degradation?and action in isolated rat heptocytes.Diabetes?1990?39:570-574.8.ChibalinAV, LengY, VieiraE, et al. Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance[J]. Cell, 2008, 132(3):375-386. DOI: 10.1016/j.cell.2007.12.035.9.KuaKL, HuS, WangC, et al. Fetal hyperglycemia acutely induces persistent insulin resistance in skeletal muscle[J]. J Endocrinol, 2019, 242(1):M1-M15. DOI: 10.1530/JOE-18-0455.10.Kunz HE, Hart CR, Gries KJ, et al. Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity[J]. Am J Physiol Endocrinol Metab, 2021, 321(1): E105-E121. DOI: 10.1152/ajpendo.00070.2021.11.Turner MC, Martin NRW, Player DJ, et al. Characterising hyperinsulinemia?induced insulin resistance in human skeletal muscle cells[J]. J Mol Endocrinol, 2020, 64(3):125?132. DOI: 10.1530/JME?19?0169.12.Abdul?Ghani M, DeFronzo RA. Insulin resistance and hyperinsulinemia: the egg and the chicken[J]. J Clin Endocrinol Metab, 2021, 106(4): e1897?e1899. DOI:10.1210/clinem/dgaa364.13.Janssen J. Hyperinsulinemia and its pivotal role in aging,obesity, type 2 diabetes, cardiovascular disease and cancer[J]. Int J Mol Sci, 2021, 22(15): 7797. DOI: 10.3390/ijms22157797.14.BrownAE, WalkerM. Genetics of insulin resistance and the metabolic syndrome[J]. Curr Cardiol Rep, 2016, 18(8):75. DOI: 10.1007/s11886-016-0755-415.Samms RJ, Coghlan MP, Sloop KW. How May GIP Enhance the Therapeutic Efficacy of GLP-1?. Trends Endocrinol Metab. 2020;31(6):410-421. doi:10.1016/j.tem.2020.02.00616.王倩,管小琴.非酒精性脂肪肝病与胰岛素抵抗[J].中国临床康复,2006,10(36):149-151.DOI:10.3321/j.issn:1673-8225.2006.36.062.17.于冬妮,郭立新.骨骼肌内脂肪沉积对肌肉功能及代谢的影响[J].国际内分泌代谢杂志,2022,42(2):134-137.DOI:10.3760/cma.j.cn121383-20201221-12060.18.邹大进. 消除胰岛素抵抗,去除慢病的“共同土壤” [J] . 中华全科医师杂志, 2022, 21(11) : 1007-1012. DOI: 10.3760/cma.j.cn114798-20220910-00909.19.Grundy SM, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005 Oct 25;112(17):2735-52. 20.Nauck MA, Meier JJ. GIP and GLP-1: stepsiblings rather than monozygotic twins within the incretin family. Diabetes. 2019;68(5):897-900. doi:10.2337/dbi19-000521.Gribble FM.Reimann F.INature Reviews Endocrinology.2019:15(4):226-237.22.Varol C, et al. J Immunol 2014,193(8):4002-400923. 于大红,马晓伟,黄佳.葡萄糖依赖性促胰岛素分泌多肽及其受体与2型糖尿病及心血管疾病的研究进展[J].中国糖尿病杂志,2019,27(12):949-952.DOI:10.3969/j.issn.1006-6187.2019.12.014.24. 孔树佳,付继华.胰岛素抵抗与糖、脂代谢紊乱[J].中国老年学杂志,2009,29(18):2403-2405.DOI:10.3969/j.issn.1005-9202.2009.18.06125.Khan R, et al. Peptides 2020,125:170201.26.Da-jin Zou et al. A novel refined classification system for type 2 diabetes in adults: A Chinese retrospective cohort study.Diabetes Metab Res Rev. 2022 Nov;38(8):e3577. doi: 10.1002/dmrr.3577. Epub 2022 Oct 3.27.Riddle, M.C., Cefalu, W.T., Evans, P.H. et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetologia (2021). https://doi.org/10.1007/s00125-021-05542-z 声明:本文仅供医疗卫生专业人士了解最新医药资讯参考使用,不代表本平台和作者观点。该信息不能以任何方式取代专业的医疗指导,也不应被视为诊疗建议,如果该信息被用于资讯以外的目的,本站及作者不承担相关责任。